THE year started with the belated adoption by the European Central Bank of quantitative easing (QE)—creating money to buy bonds—in the euro area. As the year ends, QE, which loosens monetary policy even when there is little scope to cut interest rates further, is being extended by an extra six months, so that the purchases will last until March 2017. Does this mean that the ECB’s monetary medicine is proving less effective than expected?